Monitor the company's cash burn rate and progress on PRECURSOR demonstration reactor completion by end of 2026, as well as regulatory milestones with the U.S. NRC and French ASNR. The post-SPAC cash position of ~€233M provides runway, but the widening net loss and operating cash burn of €53.7M in H1 indicate the company remains in a pre-commercial development stage.
Price Chart
Executive Summary
newcleo plc reported its first half 2026 financial results, showing revenue growth of 46% to €19.4 million but a net loss increase of 10% to €82.0 million, driven by higher share-based compensation and transaction costs. The company completed its SPAC business combination with NewHold Investment Corp III on September 21, 2026, raising gross proceeds of approximately $247 million, and listed on Nasdaq. Cash and cash equivalents stood at €66.5 million as of June 30, 2026, but improved to approximately €233 million as of September 30, 2026 following the business combination.
Key Facts
- Revenue from Products and Services increased 46% to €19.4 million for H1 2026 vs €13.3 million in H1 2025
- Net loss widened 10% to €82.0 million for H1 2026 vs €74.3 million in H1 2025
- Operating loss was €81.1 million for H1 2026 vs €75.5 million in H1 2025
- Cash and cash equivalents were €66.5 million as of June 30, 2026, down from €105.3 million at December 31, 2025
- SG&A expenses increased 21% to €59.2 million, driven by share-based payment expense of €21.0 million and transaction costs
- Completed business combination with NewHold Investment Corp III on September 21, 2026, raising gross proceeds of approximately $247 million
- Preliminary unaudited cash and cash equivalents stood at approximately €233 million as of September 30, 2026
- Basic and diluted loss per share was €0.16 for H1 2026, unchanged from H1 2025
- Total ordinary shares outstanding as of closing of business combination: 281,534,950
Financial Impact
Net loss increased by €7.7 million (10%) to €82.0 million; operating cash burn was €53.7 million for H1 2026
Risk Factors
- Continued operating losses and negative cash flow from operations
- Dependence on additional financing to fund ongoing operations and planned development activities
- Execution risk on PRECURSOR demonstration reactor and regulatory approvals
- Share-based compensation expense of €21.0 million significantly increased SG&A costs
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001140361-26-038557 |
| Document: ny20082989x2_ex99-1.htm | 0001140361-26-038557 |
| Document: ny20082989x2_6k.htm | 0001140361-26-038557 |
| Document: 0001140361-26-038557-index-headers.html | 0001140361-26-038557 |
| Document: 0001140361-26-038557-index.html | 0001140361-26-038557 |
| Document: 0001140361-26-038557.txt | 0001140361-26-038557 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 9d ago | EFFECT | $4.75 $4.32 | ▲ +9.16% | ▲ +9.01% | $4.40 (+7.37%) |
Oct 15, 2026 12d ago | SC 13G | $6.37 $4.25 | ▼ −33.36% | ▼ −32.34% | $4.40 (−30.93%) |
Oct 15, 2026 12d ago | SC 13G | $6.37 $4.25 | ▼ −33.36% | ▼ −32.34% | $4.40 (−30.93%) |
Oct 14, 2026 13d ago | 6-K | $6.37 $4.25 | ▼ −33.36% | ▼ −32.34% | $4.40 (−30.93%) |
Oct 6, 2026 21d ago | F-1 | $7.91 $6.31 | ▲ +20.23% | ▲ +19.25% | $4.40 (+44.37%) |
Oct 6, 2026 21d ago | 6-K | $7.91 $6.31 | ▼ −20.23% | ▼ −19.25% | $4.40 (−44.37%) |
Oct 5, 2026 22d ago | 6-K | $8.53 $7.37 | ▲ +13.60% | ▲ +14.02% | $4.40 (+48.42%) |
Oct 2, 2026 25d ago | Press Release | $7.99 $7.47 | ▼ −6.51% | ▼ −7.67% | $4.40 (−44.93%) |
Sep 25, 2026 4w ago | 6-K | $7.60 $8.53 | ▲ +12.24% | ▲ +11.03% | $4.40 (−42.11%) |
Sep 22, 2026 5w ago | 6-K | $7.83 $7.85 | ▲ +0.26% | ▲ +0.93% | $4.40 (−43.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers